View Older Stories View More Recent Stories

Oct 14, 2015 04:17PM Form SC 13G Zynerba Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, LLC

Oct 13, 2015 09:34AM Form 4 Aclaris Therapeutics, For: Oct 07 Filed by: RA CAPITAL MANAGEMENT, LLC

Oct 13, 2015 09:28AM Form SC 13G Aclaris Therapeutics, Filed by: RA CAPITAL MANAGEMENT, LLC

Oct 13, 2015 08:00AM Audentes Therapeutics Raises $65 Million in Series C Financing

Oct 8, 2015 04:15PM Form SC 13G ZOGENIX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC

Sep 29, 2015 05:10PM Form SC 13G/A SANGAMO BIOSCIENCES INC Filed by: RA CAPITAL MANAGEMENT, LLC

Sep 28, 2015 07:00AM Zafgen Announces Transition of Board of Directors

Sep 21, 2015 07:15AM Akari Therapeutics Closes $75 Million Private Placement

Sep 18, 2015 07:32AM Celsus Therapeutics (CLTX) Closes Acquisition of Volution Immuno Pharma

Sep 18, 2015 07:32AM Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce Completion of Acquisition and Formation of Complement C5 Inhibitor Company Akari Therapeutics Plc

Aug 24, 2015 04:26PM RA Capital Shows New 9.6% Stake in Aquinox Pharmaceuticals (AQXP)

Aug 24, 2015 04:09PM Form SC 13G AQUINOX PHARMACEUTICALS, Filed by: RA CAPITAL MANAGEMENT, LLC

Aug 19, 2015 12:56PM Unusual 11 Mid-Day Movers 8/19: (CLTX) (HILL) (ACI) Higher; (RYAM) (TEDU) (FLXS) Lower

Aug 18, 2015 08:00AM WAVE Life Sciences Raises $66 Million in Series B Financing

Aug 18, 2015 07:18AM Celsus Therapeutics (CLTX), Volution Immuno Announce $75M Private Placement

Aug 18, 2015 07:16AM Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce $75 Million Private Placement

Aug 13, 2015 04:25PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Jun 30

Jul 23, 2015 09:00AM Ra Pharmaceuticals Announces $58.5M Series B Financing

Jul 22, 2015 04:00AM KalVista Pharmaceuticals Raises $33 Million to Advance Development of Novel Plasma Kallikrein Inhibitors in Diabetic Macular Edema and Hereditary Angioedema

Jul 8, 2015 10:20AM PlacementTracker Publishes First Half 2015 PIPE Market League Tables

Jul 7, 2015 06:03AM Form SC 13G ALCOBRA LTD. Filed by: RA CAPITAL MANAGEMENT, LLC

Jul 2, 2015 02:32AM Cortendo AB: Cortendo Provides 2015 Half-Year Update on Corporate Progress

Jun 25, 2015 04:42PM Form SC 13G ARCA biopharma, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC

Jun 23, 2015 09:32AM Clementia Pharmaceuticals Raises U.S. $60 Million in Mezzanine Financing to Support Development of Palovarotene for Fibrodysplasia Ossificans Progressiva

Jun 17, 2015 09:00AM ARCA biopharma Announces Closing of $37 Million Private Placement

Jun 11, 2015 08:50AM ARCA biopharma Announces $37 Million Private Placement

Jun 5, 2015 05:14PM Form SC 13G ARDELYX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC

Jun 4, 2015 07:30AM Calhoun Vision Raises $69 Million in Financing

Jun 3, 2015 06:20AM Ardelyx (ARDX) Announces $77.8M Common Stock, Warrants Offering

Jun 3, 2015 06:19AM Ardelyx to Raise $77.8 Million in a Private Placement and Announces New Product Candidate for the Treatment of Hyperkalemia to Begin Clinical Development in Mid-2015

May 15, 2015 04:16PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31

May 15, 2015 04:06PM Form SC 13G COLLEGIUM PHARMACEUTICAL Filed by: RA CAPITAL MANAGEMENT, LLC

May 14, 2015 05:29PM Form SC 13G Xencor Inc Filed by: RA CAPITAL MANAGEMENT, LLC

May 8, 2015 04:14PM Form SC 13G Blueprint Medicines Corp Filed by: RA CAPITAL MANAGEMENT, LLC

May 8, 2015 04:12PM Form SC 13G Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, LLC

Apr 21, 2015 04:50PM Form SC 13G Cidara Therapeutics, Filed by: RA CAPITAL MANAGEMENT, LLC

Apr 21, 2015 08:00AM Dimension Therapeutics Secures $65 Million in Oversubscribed Series B Financing

Apr 6, 2015 06:00AM Natera, Inc., Non-Invasive Genetic Testing Leader, Secures $55 Million in Private Financing

Apr 3, 2015 04:02PM Form SC 13G/A ACADIA PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC

Mar 30, 2015 05:24PM Aurinia Reports Fourth Quarter and Full Year 2014 Financial Results and Highlights Initiation of Its Open Label Clinical Study to Investigate the Impact of Voclosporin on Lupus Nephritis Biomarkers

Mar 25, 2015 04:55PM Form SC 13G Aurinia Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC

Mar 23, 2015 08:00AM Aeglea Biotherapeutics Raises $44 Million in Series B Financing

Mar 12, 2015 11:00AM Allergen Research Corporation Completes $80 Million Series B Financing to Advance Drug Development Portfolio for Food Allergy

Mar 10, 2015 07:00AM Collegium Pharmaceutical Raises $50 Million Financing to Support Commercial Development of Its Lead Abuse-Deterrent Product Candidate

Feb 19, 2015 06:01AM Form SC 13G/A SANGAMO BIOSCIENCES INC Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 17, 2015 04:31PM Form SC 13G/A Ocera Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 17, 2015 04:31PM Form SC 13G/A NOVAVAX INC Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 17, 2015 04:31PM Form SC 13G/A Prothena Corp plc Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 17, 2015 04:30PM Form SC 13G/A DERMA SCIENCES, INC. Filed by: RA CAPITAL MANAGEMENT, LLC

Feb 17, 2015 04:30PM Form SC 13G/A BIOCRYST PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC

View More Recent Stories View Older Stories